Skip to main content
. Author manuscript; available in PMC: 2016 Nov 29.
Published in final edited form as: Leuk Lymphoma. 2013 Jan 23;54(9):1959–1964. doi: 10.3109/10428194.2012.763121

Figure 2.

Figure 2

Representative examples of variation in serum tryptase (□) and bone marrow mast cell (●) burden in patients with aggressive systemic mastocytosis not responding to mastocytosis-directed therapy. FLAG denotes fludarabine, ara-C, G-CSF.